Vaccines: from empirical development to rational design.

le Christine Rueckert, Carlos A Guzmán
Foilsithe 2012-01-01

Neutral Lipopolyplexes for In Vivo Delivery of Conventional and Replicative RNA Vaccine

le Federico Perche, Rudy Clemençon, Kai Schulze, Thomas Ebensen, Carlos A. Guzmán, Chantal Pichon
Foilsithe 2019-09-01

High individuality of respiratory bacterial communities in a large cohort of adult cystic fibrosis patients under continuous antibiotic treatment.

le Rolf Kramer, Annette Sauer-Heilborn, Tobias Welte, Ruy Jauregui, Ingrid Brettar, Carlos A Guzman, Manfred G Höfle
Foilsithe 2015-01-01

Block of death-receptor apoptosis protects mouse cytomegalovirus from macrophages and is a determinant of virulence in immunodeficient hosts.

le Linda Ebermann, Zsolt Ruzsics, Carlos A Guzmán, Nico van Rooijen, Rosaely Casalegno-Garduño, Ulrich Koszinowski, Luka Čičin-Šain
Foilsithe 2012-01-01

Nutraceuticals in the Treatment of Pulmonary Arterial Hypertension

le José L. Sánchez-Gloria, Horacio Osorio-Alonso, Abraham S. Arellano-Buendía, Roxana Carbó, Adrián Hernández-Díazcouder, Carlos A. Guzmán-Martín, Ivan Rubio-Gayosso, Fausto Sánchez-Muñoz
Foilsithe 2020-07-01

Role of Autophagy in Von Willebrand Factor Secretion by Endothelial Cells and in the In Vivo Thrombin-Antithrombin Complex Formation Promoted by the HIV-1 Matrix Protein p17

le Antonella Bugatti, Stefania Marsico, Pietro Mazzuca, Kai Schulze, Thomas Ebensen, Cinzia Giagulli, Esther Peña, Lina Badimón, Mark Slevin, Arnaldo Caruso, Carlos A. Guzman, Francesca Caccuri
Foilsithe 2020-03-01